Good morning, everyone. Damian here with the latest Senate harangue for the drug industry, green shoots in biotech sentiment, and the potential of a gene therapy eye drop.The need-to-know this morningAstraZeneca reported fourth quarter and 2023 earnings.BioNTech and Autolus announced a CAR-T cell therapy partnership.Kyverna Therapeutics, a developer of cell therapies for autoimmune diseases, priced […]
